dual gip and glp-1 receptor agonist Understand GLP-1/GIP Tirzepatide Its Effect on Current Weight Loss Therapy JCI Insight - Tirzepatide is

In contrast, long-acting agents appear to have a larger effect on lowering fasting glucose due to their effect to increase insulin release and inhibit glucagon release (Meier 2012)

(2025) 16:1517272/FULL

The result is not one therapeutic system, but two overlapping systems built on the same pharmacological foundation

Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: A multicentre, randomized, double-blind, placebo-controlled phase 3a clinical trial

Remind clients to not rely on hunger to eat, as they may not get hungry

To reduce digestive discomfort, try eating smaller, more frequent meals and avoid greasy, high-fat, or heavily processed foods especially on the days you take your injection